🚀 Another success! I received a SONATA grant in 2025 from NCN for our new project:
“New Horizons in Cancer Immunotherapy: Blocking LAG-3/FGL1 Interactions” — this time focusing on FGL1, the second LAG-3 ligand.
Funding: 2M PLN
Excited for what’s ahead! #LAG3 #DrugDiscovery